Therefore, we aimed to establish stable clones of the IL-33-overexpressing HNSCC cells and an animal model to confirm whether IL-33 exerts an autocrine effect on cancer cells in addition to the paracrine effect of CAF-induced IL-33, which increases the aggressiveness of HNSCC. The gene discussed is IL33; the disease is cancer.